Replay available

Mineralys Therapeutics, Inc. (MLYS) Q1 2026 Earnings Call

Mineralys Therapeutics, Inc. (NASDAQ: MLYS) Q1 2026 earnings conference call, held 2026-05-06. Replay captured from the company's public earnings webcast.

Wed, May 6, 2026 at 4:30 PMendedReplay
Mineralys Therapeutics, Inc. (MLYS) Q1 2026 Earnings Call

Hosted by

Featured presenters

Dan Ferry

Host, Life Science Advisors

John Congleton

Chief Executive Officer, Mineralis Therapeutics

Adam Levy

Chief Financial Officer, Mineralis Therapeutics

Eric Warren

Chief Commercial Officer, Mineralis Therapeutics

Michael DeFore

Analyst, Evercore

Richard Law

Analyst, Goldman Sachs

Seamus Fernandez

Analyst, Guggenheim Partners

Mohit Bansal

Analyst, Wells Fargo

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Mineralys Therapeutics, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.115 Welcome to the Minor Alice Therapeutics first quarter 2026 00:00:05.438 -- 00:00:10.345 conference call. It is now my pleasure to introduce your host, Dan Ferry of Life Science 00:00:10.345 -- 00:00:13.887 Advisors. Please go ahead, sir. 00:00:14.531 -- 00:00:18.336 Thank you. I would like to welcome everyone joining us today for our first quarter 2026 00:00:18.336 -- 00:00:23.503 conference call. This afternoon, after the close of market trading, we issued a press 00:00:23.503 -- 00:00:28.347 release providing our first quarter 2026 financial results and business updates. 00:00:28.347 -- 00:00:32.391 A replay of today's call will be available on the investor section of our website approximately 00:00:32.391 -- 00:00:34.894 one hour after its completion. 00:00:34.894 -- 00:00:39.379 After our prepared remarks, we will open up the call for Q&A. 00:00:39.379 -- 00:00:42.763 Before we begin, I would like to remind everyone that this conference call and webcast 00:00:42.763 -- 00:00:46.247 will contain forward-looking statements about the company. 00:00:46.247 -- 00:00:50.411 Actual results could differ materially from those stated or implied by these forward-looking 00:00:50.411 -- 00:00:55.135 statements due to risks and uncertainties associated with the company's business. 00:00:55.634 -- 00:00:59.019 These forward-looking statements are qualified by the cautionary statements contained 00:00:59.019 -- 00:01:04.166 in today's press release and our SEC filings, including our annual report 00:01:04.166 -- 00:01:07.891 on Form 10-K and subsequent filings. 00:01:07.891 -- 00:01:11.616 Please note that these forward-looking statements reflect our opinions only as of today, 00:01:11.616 -- 00:01:15.101 May 6, 2026. Except 00:01:15.101 -- 0...